Annual Shareholders Equity
-$24.68 M
-$13.94 M-129.80%
December 31, 2023
Summary
- As of February 8, 2025, VTVT annual stockholders equity is -$24.68 million, with the most recent change of -$13.94 million (-129.80%) on December 31, 2023.
- During the last 3 years, VTVT annual shareholders equity has risen by +$55.42 million (+69.19%).
- VTVT annual shareholders equity is now -153.39% below its all-time high of -$9.74 million, reached on December 31, 2021.
Performance
VTVT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$15.01 M
-$1.47 M-8.90%
September 30, 2024
Summary
- As of February 8, 2025, VTVT quarterly stockholders equity is $15.01 million, with the most recent change of -$1.47 million (-8.90%) on September 30, 2024.
- Over the past year, VTVT quarterly shareholders equity has dropped by -$1.47 million (-8.90%).
- VTVT quarterly shareholders equity is now -27.83% below its all-time high of $20.80 million, reached on March 31, 2024.
Performance
VTVT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VTVT Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -129.8% | -8.9% |
3 y3 years | +69.2% | +159.4% |
5 y5 years | +70.2% | +121.6% |
VTVT Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -153.4% | at low | -27.8% | +159.4% |
5 y | 5-year | -153.4% | +69.2% | -27.8% | +118.7% |
alltime | all time | -153.4% | +91.9% | -27.8% | +109.9% |
VTv Therapeutics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $15.01 M(-8.9%) |
Jun 2024 | - | $16.48 M(-20.8%) |
Mar 2024 | - | $20.80 M(-184.3%) |
Dec 2023 | -$24.68 M(+129.8%) | -$24.68 M(-2.2%) |
Sep 2023 | - | -$25.23 M(-0.2%) |
Jun 2023 | - | -$25.28 M(+31.7%) |
Mar 2023 | - | -$19.19 M(+78.7%) |
Dec 2022 | -$10.74 M(+10.3%) | -$10.74 M(-35.2%) |
Sep 2022 | - | -$16.57 M(+94.3%) |
Jun 2022 | - | -$8.53 M(+5.4%) |
Mar 2022 | - | -$8.09 M(-16.9%) |
Dec 2021 | -$9.74 M(-87.8%) | -$9.74 M(-54.8%) |
Sep 2021 | - | -$21.55 M(-54.9%) |
Jun 2021 | - | -$47.82 M(-15.0%) |
Mar 2021 | - | -$56.27 M(-29.7%) |
Dec 2020 | -$80.10 M(+63.4%) | -$80.10 M(+55.9%) |
Sep 2020 | - | -$51.37 M(-26.1%) |
Jun 2020 | - | -$69.53 M(+12.5%) |
Mar 2020 | - | -$61.82 M(+26.1%) |
Dec 2019 | -$49.02 M | -$49.02 M(+4.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | -$47.15 M(-5.5%) |
Jun 2019 | - | -$49.90 M(-13.6%) |
Mar 2019 | - | -$57.73 M(-30.3%) |
Dec 2018 | -$82.85 M(-45.1%) | -$82.85 M(+88.4%) |
Sep 2018 | - | -$43.98 M(-38.6%) |
Jun 2018 | - | -$71.60 M(-51.9%) |
Mar 2018 | - | -$148.79 M(-1.5%) |
Dec 2017 | -$151.05 M(+66.1%) | -$151.05 M(+10.8%) |
Sep 2017 | - | -$136.30 M(+28.1%) |
Jun 2017 | - | -$106.41 M(-13.8%) |
Mar 2017 | - | -$123.47 M(+35.8%) |
Dec 2016 | -$90.94 M(+16.6%) | -$90.94 M(-18.2%) |
Sep 2016 | - | -$111.24 M(+39.9%) |
Jun 2016 | - | -$79.52 M(+26.2%) |
Mar 2016 | - | -$63.02 M(-19.2%) |
Dec 2015 | -$77.97 M(+28.4%) | -$77.97 M(-17.2%) |
Sep 2015 | - | -$94.19 M(+16.4%) |
Jun 2015 | - | -$80.94 M(+14.8%) |
Mar 2015 | - | -$70.53 M(+16.2%) |
Dec 2014 | -$60.72 M(-80.0%) | -$60.72 M |
Dec 2013 | -$303.73 M | - |
FAQ
- What is vTv Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for vTv Therapeutics?
- What is vTv Therapeutics annual shareholders equity year-on-year change?
- What is vTv Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for vTv Therapeutics?
- What is vTv Therapeutics quarterly shareholders equity year-on-year change?
What is vTv Therapeutics annual stockholders equity?
The current annual shareholders equity of VTVT is -$24.68 M
What is the all time high annual shareholders equity for vTv Therapeutics?
vTv Therapeutics all-time high annual stockholders equity is -$9.74 M
What is vTv Therapeutics annual shareholders equity year-on-year change?
Over the past year, VTVT annual stockholders equity has changed by -$13.94 M (-129.80%)
What is vTv Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VTVT is $15.01 M
What is the all time high quarterly shareholders equity for vTv Therapeutics?
vTv Therapeutics all-time high quarterly stockholders equity is $20.80 M
What is vTv Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VTVT quarterly stockholders equity has changed by -$1.47 M (-8.90%)